AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)
AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)

Cash Flow ADMS Quote Adamas Phar

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome -60 -89 -131
Depreciation 1 1 1
DeferredIncomeT 0 0 0
StockBasedCompe 11 13 16
AccountsReceiva 0 0 -5
InventoryCS 0 -2 -3
AccountsPayable 1 0 3
OtherWorkingCap 0 0 0
OtherNonCashIte 0 4 19
NetCashProvided -48 -67 -104
InvestmentsInPP -2 -1 -1
AcquisitionsNet 0 0 0
PurchasesOfInve -104 -63 -200
SalesMaturities 78 89 132
PurchasesOfInta 0 0 0
OtherInvestingA 0 0 0
NetCashUsedForI -27 26 -69
DebtIssued 0 100 0
DebtRepayment 0 0 0
CommonStockIssu 62 0 134
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 4 9 5
NetCashProvided 65 109 139
NetChangeInCash -9 68 -35
CashAtBeginning 33 24 91
CashAtEndOfPeri 24 91 57
Adamas Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Adamas Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.